A new pill for weight loss in obesity and overweight
Part of Hormones & metabolism clinical trials.
This study tests an investigational pill called aleniglipron to see if it helps people with obesity or overweight who also have a weight-related health problem (like high blood pressure) lose weight safely. It is a Phase 3 trial, meaning it is in the final stages before seeking approval.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults with obesity (BMI of 30 or more) or overweight (BMI of 27 or more) plus at least one weight-related health issue like high blood pressure, high cholesterol, or sleep apnea.
- You must not have any type of diabetes.
- Your weight has been steady — not a gain or loss of more than 11 pounds in the past 3 months.
- You have not had and do not plan to have weight-loss surgery or other procedures like a stomach balloon.
- Your obesity is not due to another medical condition like a hormone problem, and you must not have kidney problems or chronic malabsorption (trouble absorbing nutrients).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new daily pill (aleniglipron) to help adults with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be a good fit if you have a BMI of 27 or higher and your diabetes is managed with A1c between 6.5% and 10%.
This trial tests a new medicine, orforglipron, to help people with overweight who are at risk of developing weight-related health issues. It aims to see if the medicine can help with weight management and reduce risks before more serious conditions develop.
This study tests a once-daily pill called ASC30 to help adults with obesity or overweight who also have conditions like high blood pressure, sleep apnea, or heart disease lose weight. The pill may work by affecting appetite and blood sugar, and the study aims to see how effective and safe it is.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This study tests an investigational medication, orforglipron, taken as a pill to help people with excess weight lose weight. It may be an option for people who have not been able to lose weight with diet alone and who also have weight-related health problems.
This study tests an investigational medication called elecoglipron for weight loss in Asian adults who are overweight or have obesity, with or without type 2 diabetes. It may help participants lose weight and improve health.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.